Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of sitagliptin + metformin vs Janumet in healthy Thai volunteers (fed)
TCTR20230616001Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sitagliptin + metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
sitagliptin + metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20230616001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230616001.